🤝 Anupam Rasayan’s $155M Jayhawk Acquisition Powers US Expansion in Specialty Chemicals

Anupam Rasayan India Limited

has signed a definitive agreement to acquire Monitchem Kansas S.àr.l and subsidiaries, including Jayhawk Fine Chemicals Corporation, for up to $155 million from CABB Europe GmbH. Jayhawk, with 2024 revenues of $78 million and EBITDA of $15 million, specializes in custom manufacturing of fine chemicals, advanced intermediates, and active ingredients for agrochemicals, specialty chemicals, and performance materials like dianhydrides and polyimide precursors used in semiconductors.​ This deal marks Anupam’s entry into US onshore manufacturing, expanding its polymer portfolio and securing an established American customer base amid global supply chain shifts. Financed via internal accruals, debt, and quasi-equity from a major global investor, the $134 million enterprise value (post-cash adjustments) aligns with Anupam’s growth strategy, building on 45% YoY fixed asset growth in FY25.​ For a lone market watcher tracing chemical deal maps at dusk, Anupam’s bold US foothold spotlights specialty chem stocks: peers like PI Industries Limited , Navin Fluorine International Limited , and SRF Limited gain from inorganic expansion themes as India Inc eyes global CDMO scale. Imagine a Gujarat chemist peering at Kansas blueprints, reactors syncing across oceans—each molecule bridging continents, fueling chips and crops. Anupam’s acquisition isn’t ink on paper; it’s India claiming a seat at the high-value chemical table, one US plant at a time. 📌 Learning Takeaway: Anupam’s $155M Jayhawk buy establishes US manufacturing foothold, enhancing specialty chemical capabilities for global agro and semi markets.​